Skip to main content

IndexIQ Advisors LLC

SEC CIK
0001415996
Latest filing
May 6, 2022

TCRR holding history

TCR2 Therapeutics Inc. in every 13F filed by IndexIQ Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TCRR overviewAll 13F holders of TCRRFull Q1 2022 holdings

Shares (Q1 2022)
0
Sold out in Q1 2022
Value
$0
% of portfolio
0.0%
Quarters held
4
Since Q1 2021
Holdings of TCRR by IndexIQ Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20220$00.0%−19,126−100.0%Sold outHolders
Q4 202119,126$89.0K<0.1%−1,236−6.1%ReducedHolders
Q3 202120,362$173.0K<0.1%+2,039+11.1%AddedHolders
Q2 202118,323$301.0K<0.1%−900−4.7%ReducedHolders
Q1 202119,223$424.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.